<DOC>
	<DOCNO>NCT02445040</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness Babylog VN500 high frequency oscillatory ventilation ( HFOV ) mode method treat low birth weight ( VLBW ) neonates require invasive respiratory support treatment respiratory distress .</brief_summary>
	<brief_title>Safety Efficacy Study Draeger Babylog VN500 Device HFOV Mode VLBW Neonates</brief_title>
	<detailed_description>Results single-arm , multi-center clinical study intend evaluate safety effectiveness Babylog VN500 device high frequency oscillatory ventilation ( HFOV ) mode low birth weight ( VLBW ) neonates 23 30 week ' gestational age ( 400 g 1200 g , inclusive ) document respiratory distress require invasive respiratory support . The safety determine evaluate rate subject alive Day 32 free Grade III/IV intraventricular hemorrhage ( IVH ) cystic periventricular leukomalacia . Evaluation Alveolar-arterial ( A-a ) gradient 12 hour start ventilation account effectiveness .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<criteria>Gestational Age 23 30 week ; within first 4 day life low birth weight 400 g 1200 g , inclusive 5minute Apgar score &gt; 3 documented respiratory distress require invasive respiratory Support A priori : primary intention either HFOV highfrequency jet ventilation OR Severity Illness : mechanical ventilation fraction inspire oxygen ≥ 0.25 % mean airway pressure ≥ 7 cm H2O , 2 hour initial dose surfactant require clinical care team believe treatment HFOV indicate anticipated availability investigational device study center screen enrollment write informed consent participate study provide parent legal guardian anticipation require intubation mechanical ventilation le 12 hour previous exposure mechanical ventilation ≥ 96 hour plan HFOV treatment obvious chromosomal major congenital abnormality involve respiratory tract upper airway know congenital heart disease , exclude Patent Ductus Arteriosus ( PDA ) , ventricularseptal defect , atrialseptal defect preexist air leak , include pneumothorax , pneumomediastinum , pneumopericardium , extensive bilateral Pulmonary Interstitial Emphysema ( PIE ) severe metabolic acidosis base deficit ≥ 15 planned HFOV treatment severe hypotension ( mean blood pressure 2 standard deviation mean neonate 's birth weight despite total combine dose dopamine , dobutamine , , 20 µg ( kg/min ) moribund subject expect survive , subject decision limit care currently receive previous treatment inhale nitric oxide currently receive previous treatment corticosteroid specifically BPD prevention evidence severe sepsis ( neutropenia , severe hypotension , shock ) evidence Nectrotising Enterocolitis ( NEC ) , define Modified Bell 's Stage II great document Grade III/IV intraventricular hemorrhage current enrollment another Investigational Device Exemption Investigational New Drug clinical study treatment , test , followup may interfere result</criteria>
	<gender>All</gender>
	<minimum_age>23 Weeks</minimum_age>
	<maximum_age>30 Weeks</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>High Frequency Oscillatory Ventilation</keyword>
	<keyword>Infant , Very Low Birth Weight</keyword>
	<keyword>Periventricular Leukomalacia</keyword>
	<keyword>Intraventricular Hemorrhage</keyword>
	<keyword>multi-center study</keyword>
</DOC>